Patent application number | Description | Published |
20090121611 | PLASMA DISPLAY PANEL - A plasma display panel (PDP) is provided. The PDP includes: a first substrate and a second substrate facing each other; a plurality of first barrier ribs on the second substrate defining a plurality of cells between the first substrate and the second substrate; pairs of scan electrodes and sustain electrodes on the first substrate; a plurality of second barrier ribs each dividing a corresponding cell of the cells into a primary discharge space and an auxiliary discharge space; a plurality of address electrodes on the second substrate. A portion of an address electrode among the address electrodes corresponding to the auxiliary discharge space is wider than other portions of the address electrode, thereby providing an improved addressing discharge. | 05-14-2009 |
20090128036 | PLASMA DISPLAY PANEL - A plasma display panel (PDP) having high driving efficiency obtained by improving an address voltage margin; having high image quality obtained by removing noisy brightness such as discharge light generated when an address discharge occurs or background light; and suitable for an image display with high efficiency and high resolution. The PDP includes a plurality of first barrier ribs between a first substrate and a second substrate, the first barrier ribs defining a plurality of unit cells; and a plurality of second barrier ribs dividing each of the unit cells into a main discharge space and an auxiliary discharge space. A row of the auxiliary discharge spaces is adjacent and between two rows of the main discharge spaces. The PDP also includes a phosphor layer in the main discharge spaces; and a plurality of grooves in the second barrier ribs between the main discharge spaces and the auxiliary discharge spaces. | 05-21-2009 |
20100117512 | PLASMA DISPLAY PANEL - A plasma display panel is disclosed. The plasma display panel has discharge cells which each have a range of widths between the first substrate and the second substrate. In addition, the discharge spaces are separated by non-discharge spaces having heights which are less than the heights of the discharge spaces. | 05-13-2010 |
20100117513 | PLASMA DISPLAY PANEL - A plasma display panel is disclosed. The plasma display panel has discharge cells which each have a range of widths between the first substrate and the second substrate. In addition, the discharge spaces are separated by non-discharge spaces having heights substantially the same as the heights of the discharge spaces. | 05-13-2010 |
20100207510 | Plasma display panel and method of manufacturing the same - A plasma display panel (PDP) and a method of manufacturing the same with improved luminous efficiency. The PDP includes: a first substrate; a second substrate facing the first substrate; a plurality of sustain electrode pairs between the first substrate and the second substrate and extending in a first direction; a plurality of address electrodes on the second substrate and extending in a second direction crossing the first direction; a first dielectric layer on the second substrate for covering the address electrodes; a discharge enhancement layer on the first dielectric layer; a plurality of barrier ribs on the discharge enhancement layer and defining discharge cells between the first and second substrates; and phosphor layers in the discharge cells, wherein the discharge enhancement layer has an opening in each of the discharge cells, and wherein the barrier ribs have a roughness less than that of the discharge enhancement layer. | 08-19-2010 |
20110068677 | PLASMA DISPLAY PANEL - A plasma display panel (PDP) is disclosed. In one embodiment, the PDP includes i) a front substrate and a rear substrate spaced apart from and facing each other and ii) a barrier rib portion dividing a space between the front substrate and the rear substrate into a plurality of discharge cells, wherein the barrier rib portion comprises first barrier ribs and second barrier ribs formed on the first barrier ribs, wherein the second barrier ribs are less in width than the first barrier ribs, wherein the widths of the first and second barrier ribs are defined along a first direction substantially parallel with one of the front and rear substrates, and wherein the second barrier ribs are closer to the first substrate than the first barrier ribs. The PDP may further include i) an anti-reflection layer formed on the second barrier ribs, ii) a plurality of discharge electrodes separately disposed on the front substrate substantially in parallel with each other across the front substrate, iii) a plurality of address electrodes formed on the rear substrate to cross the discharge electrodes, iv) phosphors formed in the discharge cells and v) a discharge gas filled in the discharge cells. | 03-24-2011 |
Patent application number | Description | Published |
20080312337 | Anticancer Composition Comprising Obovatol or Obovatal - Disclosed herein is an anticancer composition, comprising obovatol, represented by the following Chemical Formula 1, obovatal, represented by the following Chemical Formula 2, and/or pharmaceutical salts thereof. The composition exhibits the activity of inhibiting the growth of cancer cells and suppressing the expression and activity of matrix metalloproteinases (MMPs), and thus can be useful for the prophylaxis and treatment of cancer as well as for the inhibition of cancer metastasis. | 12-18-2008 |
20100184949 | Method for the mass expression of an antimicrobial peptide by using a translational coupling system - The present invention relates to a gene construct which is capable of achieving efficient production of an antimicrobial peptide in a microorganism, and a method for efficient mass production and separation of an antimicrobial peptide using the same. The gene construct of the present invention has a translationally coupled configuration of two independent and separate cistrons which encode an acidic peptide and a basic antimicrobial peptide, each having an opposite charge, under the control of a single promoter. The translationally coupled acidic peptide and basic antimicrobial peptide undergo charge-charge interaction simultaneously with expression thereof to neutralize the potential cytotoxicity of the antimicrobial peptide, resulting in prevention of antimicrobial peptide-mediated killing of host microorganisms. In addition, a conjugate of the acidic peptide and the antimicrobial peptide can be separated without chemical or enzymatic treatment. Therefore, it is possible to achieve easy mass production of antimicrobial peptides from recombinant microorganisms. | 07-22-2010 |
Patent application number | Description | Published |
20090298541 | STACKING TYPE SIM CARD CONNECTOR AND MOBILE TERMINAL HAVING THE SAME - A Subscriber Identity Module (SIM) card connector of a mobile terminal is provided. The SIM card connector includes a housing for mounting one or more SIM cards therein, a separation plate separating an internal space of the housing for mounting the one or more SIM cards in a stacked arrangement within the housing and at least one contact point for electrically connecting to at least one of the one or more SIM cards. Thereby, the SIM card connector for mounting two SIM cards in a stacked arrangement enables a dual SIM card mobile terminal requiring 1.5 times more parts than those of a general mobile terminal to effectively utilize available space. | 12-03-2009 |
20140131425 | METHOD OF DETECTING WIRE BONDING FAILURES - Disclosed is a method of detecting a bonding failure of a wire bonder, which comprises a bonding tool operative to form an electrical connection between a semiconductor die and a substrate using a bonding wire. The method comprises the steps of: forming a first wire bond on a first surface located on the semiconductor die using the bonding tool and the bonding wire; forming a second wire bond on a second surface located on the substrate using the bonding tool and the bonding wire such that a wire loop connects the first and second wire bonds, wherein the first surface is not electrically-conductive; moving the bonding tool in a direction away from the second wire bond to break the bonding wire from the second wire bond; detecting whether the second wire bond remains bonded to the substrate; and determining an occurrence of the bonding failure if the second wire bond is no longer bonded to the substrate. | 05-15-2014 |
20150086553 | POLYPEPTIDE BINDING TO ANNEXIN A1 AND USE THEREOF - A polypeptide binding to Annexin A1, an antagonist against Annexin A1 including the polypeptide, an anti-Annexin A1 antibody including the polypeptide or an antigen-binding fragment thereof, and methods of preventing, treating and/or diagnosing a disease, including administering the antagonist and/or the antibody or an antigen-binding fragment thereof to a subject. | 03-26-2015 |
20150119340 | FUSION PEPTIDE AND USE THEREOF FOR CELL MEMBRANE PENETRATING - A fusion peptide including a hydrophobic peptide and a basic peptide, a pharmaceutical composition including the fusion peptide, a cell membrane penetrating conjugate including the fusion peptide and a substance of interest, and a method for intracellular delivery of a substance of interest using the fusion peptide. | 04-30-2015 |
20150218240 | p16 PROTEIN VARIANT AND USE THEREOF FOR PREVENTING OR TREATING CANCER - A p16 protein variant; a polynucleotide encoding the p16 protein variant; a method for preparing the p16 protein variant; a pharmaceutical composition comprising the p16 protein variant; a method for preventing and/or treating cancer comprising administering the p16 protein variant to a subject; and use of the p16 protein variant in the prophylaxis and/or therapy of cancer. | 08-06-2015 |
20150329847 | FUSION PROTEIN COMPRISING GRANZYME B AND USE THEREOF - A fusion protein including granzyme B, a cell penetrating peptide, a cleavage site, and a targeting moiety, a composition for cell membrane penetration comprising the fusion protein, and an anticancer composition comprising the fusion protein. | 11-19-2015 |